It is a pharma private limited company based in Panvel, Maharashtra, India, established in 2020.
2020 | Panvel, Maharashtra, India | ActiveSkylet Pharma Private Limited, a active private limited company, was established on 23 November 2020 in Panvel, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909MH2020PTC350510. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shiv Shankar (Additional Director), Ramesh Kumar Chaubey (Additional Director). Past directors included Kripa Shankar Mishrilal Gupta, Lalluprasad Samailal Maurya. It holds ₹4.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Shop No. 02, Arjan Niwas, Plot No. 51, Sector-6, Karanjade,, Panvel, Maharashtra, 410206.
U51909MH2020PTC350510
350510
23 November 2020
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Skylet Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Shankar | Additional Director | 13 Sep 2023 | Current |
| Ramesh Kumar Chaubey | Additional Director | 12 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Oct 2023 | Past |
| Pramod Abcsdd | Director | 16 Aug 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skylet Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 816.23% increase. The company also saw a substantial improvement in profitability, with a 38.43% increase in profit. The company's net worth Soared by an impressive increase of 74.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Skylet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2023 | Axis Bank Limited | ₹4.90 M | Open |
Explore comprehensive loan charge details -
Skylet Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Skylet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skylet Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ramesh Kumar Chaubey was appointed as a Additional Director was appointed as a Additional Director on 12 Aug 2025 & has been associated with this company since 4 months 14 days . was documented.
Progress on Skylet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Shiv Shankar was appointed as a Additional Director was appointed as a Additional Director on 13 Sep 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 4.90 M with Charge ID 100769226 was registered on 01 Jul 2023. was recorded as a recent event.
Progress on Skylet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
Skylet Pharma Private Limited was registered on 23 Nov 2020 with Roc Mumbai & aged 5 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Skylet Pharma Private Limited is U51909MH2020PTC350510.
Skylet Pharma Private Limited is headquartered at Shop No. 02, Arjan Niwas, Plot No. 51, Sector-6, Karanjade,, Panvel, Maharashtra, 410206.
Skylet Pharma Private Limited was incorporated on 23 November 2020.
The current directors of Skylet Pharma Private Limited are
The primary industry of Skylet Pharma Private Limited is Trade.
Skylet Pharma Private Limited is unlisted.
The authorized capital of Skylet Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX